Daulat B. Khadka

Gwangju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Structure-based discovery of pyrazolamides as novel ERRγ inverse agonists.

Structure-based discovery of pyrazolamides as novel ERRγ inverse agonists.

Journal: European journal of medicinal chemistry

Published: August 23, 2022

SAR study of bisamides as cyclophilin a inhibitors for the development of host-targeting therapy for hepatitis C virus infection.

SAR study of bisamides as cyclophilin a inhibitors for the development of host-targeting therapy for hepatitis C virus infection.

Journal: Bioorganic & medicinal chemistry

Published: June 02, 2020

Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.

Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.

Journal: European journal of medicinal chemistry

Published: September 19, 2019

A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis.

A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis.

Journal: The Journal of clinical investigation

Published: August 14, 2018

Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.

Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.

Journal: Bioorganic & medicinal chemistry

Published: July 22, 2018

Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors.

Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: April 05, 2018

Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.

Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.

Journal: European journal of medicinal chemistry

Published: July 20, 2017

Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.

Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.

Journal: Bioorganic & medicinal chemistry

Published: June 05, 2017

Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro.

Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro.

Journal: Pharmacological research

Published: November 09, 2016

Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects.

Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects.

Journal: Scientific reports

Published: July 04, 2016

Design and synthesis of novel androgen receptor antagonists via molecular modeling.

Design and synthesis of novel androgen receptor antagonists via molecular modeling.

Journal: Bioorganic & medicinal chemistry

Published: December 22, 2015

Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.

Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.

Journal: Journal of medicinal chemistry

Published: November 28, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026